Glutathione: An overview of biosynthesis and modulation

Chemico-Biological Interactions

Volumn 111-112, Issue , 1998, Pages 1-14

  Anderson, Mary E ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

2 Oxothiazolidine 4 carboxylate; Glutathione; GSH esters; GSH synthetase; Glutamylcysteine synthetase

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; BUTHIONINE SULFOXIMINE; CYCLOPHOSPHAMIDE; CYSTAMINE; CYSTEINE DERIVATIVE; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE SYNTHASE; MELPHALAN; METHIONINE SULFOXIMINE; PARACETAMOL; REACTIVE OXYGEN METABOLITE;

BIOSYNTHESIS; CELL METABOLISM; GLUTATHIONE METABOLISM; HUMAN; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW;

MAMMALIA;

EID: 3042802690     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00146-4     Document Type: Article

References (88)

1. A. Meister. Metabolism and function of glutathione, in: D. Dolphin, R. Poulson, O. Avramovic (Eds.), Glutathione: Chemical, Biochemical and Medical Aspects, Wiley, New York, pp. 367-474.
2. Meister A., Anderson M.E. Glutathione. Ann. Rev. Biochem. 52:1983;711-760.
3. Anderson M.E. Glutathione and Glutathione Delivery Compounds. Adv. Pharmacol. 38:1997;65-78.
4. M.E. Anderson, M.E. (1997) Modulation of Glutathione, in: L. Packer, E. Cadenas (Eds.), Handbook of Antioxidants, Marcel Dekker, New York, pp. 321-328.
5. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Therapeut. 51:1991;155-194.
6. A. Meister, On the biochemistry of glutathione, in: N. Taniguchi, T. Higashi, Y. Sakamoto, A. Meister (Eds.), Glutathione Centennial: Molecular Perspectives and Clinical Implications; Academic Press, New York, 1989, pp. 1-21.
7. Orlowski M, Meister A The γ-glutamyl cycle: a possible transport system for amino acids. Proc. Natl. Acad. Sci. U.S.A. 67:1970;1248-1255.
8. Thompson G.A. Hydrolysis and transfer reactions catalyzed by γ- glutamyl transpeptidase; evidence for separate substrate sites and for high affinity of L-cystine. Biochem. Biophys. Res. Commun. 71:1976;32-36.
9. A. Meister, Glutathione Synthesis, in: P.B. Boyer (Ed.), The Enzymes, 3rd ed, vol 10, Academic Press, New York, pp. 671-697.
10. Yan N., Meister A. Amino acid sequence of rat kidney γ-glutamycysteine synthetase. J. Biol. Chem. 265:1990;1588-1593.
11. Watanabe K., Yamano Y., Murata K., Kimura A. The nucleotide sequence of the gene for γ-glutamylcysteine synthetase of Escherichia coli. Nucleic Acids Res. 14:1986;4393-4400.
12. Gipp J.J., Chang C., Mulcahy R.T. Cloning and nucleotide sequence of a full-length cDNA for human γ-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun. 185:1992;29-35.
13. Richman P.G., Meister A. Regulation of γ-glutamylcysteine synthetase by non-allosteric feedback inhibition by glutathione. J. Biol. Chem. 250:1973;1422-1426.
14. Huang C.-S., Moore W.R., Meister A. On the active site thiol of γ-glutamylcysteine synthetase: relationships to catalysis, inhibition, and regulation. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2464-2468.
15. Griffith O.W., Anderson M.E., Meister A. Inhibition of glutathione biosynthesis by prothionine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of γ-glutamylcysteine synthetase. J. Biol. Chem. 254:1979;1205-1210.
16. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:1979;7558-7560.
17. Griffith O.W., Larsson A, Meister A. Inhibition of γ-glutamylcysteine aciduria). Biochem. Biophys. Res. Commun. 79:1977;919-925.
18. Simondsen R.P., Meister A. Interaction of the D-isomer of γ-methylene glutamate with an active site thiol of γ-glutamylcysteine synthetase. J. Biol. Chem. 261:1986;17134-17137.
19. Moore W., Wiener H.L., Meister A. Inactivation of γ-glutamylcysteine synthetase, but not of glutamine synthetase, by S-sulfocysteine and S-homocysteine. J. Biol. Chem. 262:1987;16771-16777.
20. Sekura R., Meister A. Covalent interaction of L-2-amino-4-oxo-5 chloropentanoate at the glutamate binding site of γ-glutamylcysteine synthetase. J. Biol. Chem. 252:1977;2606-2610.
21. Beamer R.L., Griffith O.W., Gass J.D., Anderson M.E., Meister A. Interaction of L- and D-3-amino-1-chloro-2-pentanone with γ-glutamylcysteine synthetase. J. Biol. Chem. 255:1980;11721-11726.
22. Seelig G.F., Simondsen R.P., Meister A. Reversible dissociation of γ-glutamylcysteine synthetase into two subunits. J. Biol. Chem. 259:1984;9345-9347.
23. Huang C.S., Chang L.S., Anderson M.E., Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney γ-glutamylcysteine synthetase. J. Biol. Chem. 268:1993;19675-19689.
24. Huang C.S., Anderson M.E., Meister A. Amino acid sequence and function of the light subunit of rat kidney γ-glutamylcysteine synthetase. J. Biol. Chem. 268:1993;20578-20583.
25. Meister A. Glutathione synthetase from rat kidney. Methods Enzymol. 113:1985;393-399.
26. Oppenheimer L., Wellner V.P., Griffith O.W., Meister A. Glutathione synthetase: purification from rat kidney and mapping of the substrate binding sites. J. Biol. Chem. 254:1979;5184-5190.
27. Dodd Mooz E., Meister A. Glutathione biosynthesis. Methods Enzymol. 17B:1973;483-495.
28. Gushima H., Yasuda S., Soeda E., Yokota M., Kondo M., Kimura A. Complete nucleotide sequence of the E. coli glutathione synthetase gsh-II. Nucleic Acid Res. 12:1984;9299-9307.
29. Kato H., Tanaka T., Nishioka T., Kimura A., Oda J. Role of cysteine residues in glutathione synthetase from Escherichia coli B.: chemical modification and oligonucleotide site-directed mutagenesis. J. Biol. Chem. 263:1988;11646-11651.
30. Kato H., Yamaguchi H., Hata Y., Nishioka T., Katsube Y., Oda J. Crystallization and preliminary X-ray studies of glutathione synthetase from Escherichia coli B. J. Mol. Biol. 209:1989;503-504.
31. Yamaguchi H., Kato H., Hata Y., Nishioka T., Kimura A., Oda J., Katsube Y. Three-dimensional structure of the glutathione synthetase from Escherichia coli B at 2.0 A resolution. J. Mol. Biol. 229:1993;1000-1083.
32. Tanaka T., Kato H., Nishioka T., Oda J. Mutational and proteolytic studies on a flexible loop in glutathione synthetase from Escherichia coli B: the loop and arginine 233 are critical for the catalytic reaction. Biochemistry. 31:1992;2259-2265.
33. Tanaka T., Yamaguchi H., Kato H., Nishioka T., Katsube Y., Oda J. Flexibility impaired by mutations revealed the multifuctional roles of the loop in glutathione synthetase. Biochemistry. 32:1993;12398-12404.
34. Kato H., Tanaka T., Yamaguchi H., Hara T., Nishioka T., Katsube Y., Oda J. Flexible loop that is novel catalytic machinery in a ligase: atomic structure and function of the loopless glutathione synthetase. Biochemistry. 33:1994;4995-4999.
35. Huang C.S., He W., Meister A., Anderson M.E. Amino acid sequence of rat kidney glutathione synthetase. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1232-1236.
36. Mutoh N., Nakagawa C.W., Ando S., Tanabe K., Hayashi Y. Cloning and sequencing of the gene encoding the large subunit of glutathione synthetase of Schizosaccharomyces pombe. Biochem. Biophys. Res. Comm. 181:1991;430-436.
37. Habennicht A., Hille S., Knochel W. Molecular cloning of the large subunit of glutathione synthetase from Xenopus laveus embryos. Biochim. Biophys. Acta. 1174:1993;295-298.
38. Gali R.R., Board P.G. Sequencing and expression of a cDNA for human glutathione synthetase. Biochem. J. 310:1995;353-358.
39. Gali R., Board P.G. Identification of an essential cysteine residue in human glutathione synthase. Biochem. J. 321:1997;207-210.
40. C.S. Huang, L.S. Chiang, A. Meister, M.E. Anderson, Mutations in a conserved domain of rat glutathione synthetase, (in preparation).
41. A. Larsson, Hereditary disorders related to glutathione deficiency, in: D. Dolphin, R. Poulson, O. Avramovic (Eds.), Glutathione: Chemical, Biochemical and Medical Aspects, Wiley, New York, 1989, pp. 197-233.
42. A. Meister, A. Larsson, Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease, 7th ed, McGraw Hill, New York, 1995, pp 1461-1477.
43. Wellner V.P., Sekura R., Meister A., Larsson A. Glutathione synthetase deficiency: an inborn error of metabolism involving the γ-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc. Natl. Acad. Sci. U.S.A. 71:1974;2969-2972.
44. A. Larsson, L. Hagenfeldt, Hereditary glutathione synthetase deficiency in man, in: A. Larsson, S. Orrenius, A. Holmgren, B. Mannervik (Eds.), Functions of Glutathione - Biochemical, Physiological, Toxicological and Clinical Aspects, Raven Press, New York, 1983, pp. 317-324.
45. Dahl N., Pigg M., Ristoff E., Gali R., Carlsson B., Mannervik B., Larsson A., Board P. Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Human Mol. Genet. 6:1997;1147-1152.
46. Rowe W.B., Meister A. Studies on the inhibition of glutamine synthetase by methionine sulfone. Biochemistry. 12:1973;1578-1582.
47. Griffith O.W., Meister A. Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions. J. Biol. Chem. 253:1978;2333-2338.
48. Suthanthiran M., Anderson M. E., Sharma V.K., Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified T-lymphocytes stimulated via CD2 and CD3 antigens. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3343-3347.
49. Calvin H.L., Medvedovsky C., Worgul B.V. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science. 233:1986;553-555.
50. Griffith O.W., Meister A. Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4668-4672.
51. Martensson J., Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc. Natl. Acad. Sci. U.S.A. 867:1989;471-475.
52. Martensson J., Jain A., Stole E., Frayer W., Auld P.A.M., Meister A. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9360-9364.
53. Martensson J., Jain A., Frayer W., Meister A. Glutathione metabolism in the lung; mitochondrial defects. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5296-5930.
54. Martensson J., Jain A., Meister A. Glutathione is required for intestinal function. Proc. Natl. Acad. Sci. U.S.A. 87:1990;7185-7189.
55. Jain A., Martensson J., Mehta T., Krauss A.N., Auld P.A.M., Meister A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant, and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5093-5097.
56. Martensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4656-4660.
57. Meister A. Glutathione-ascorbate acid antioxidant system in animals. J. Biol. Chem. 269:1994;9397-9400.
58. A. Meister, Strategies for increasing cellular glutathione, in: L. Packer, E. Cadenas (Eds.), Biothiols in Health and Disease, Marcel Dekker, New York, 1995, pp. 165-188.
59. White A.C., Thannickal V.J., Fanburg B.L. Glutathione deficiency in human disease. J. Nutr. Biochem. 5:1994;218-226.
60. Nishiuch Y, Sasaki M., Nakayasu M., Oikawa A. Cytotoxicity of cysteine in culture media. In Vitro. 12:1976;635.
61. Olney J.W., Ho O.L., Rhee V. Cytotoxic effect of acid and sulphur containing amino acids on the infant mouse central nervous system. Brain Res. 14:1971;61-76.
62. Anderson M.E., Meister A. Intracellular delivery of cysteine. Methods Enzymol. 143:1987;313-325.
63. Cooper A.J.L., Haber M.T., Meister A. On the chemistry and biochemistry of 3-mercaptopyruvate acid, the α-keto acid analog of cysteine. J. Biol. Chem. 257:1982;816-826.
64. Williamson J.M., Meister A. New substrates of 5-oxo-L-prolinase. J. Biol. Chem. 257:1982;12039-12042.
65. Williamson J.M., Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. U.S.A. 78:1981;936-939.
66. Williamson J.M., Boettcher B., Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 79:1982;6246-6249.
67. Meister A., Anderson M.E., Huang O. Intracellular delivery of cysteine and glutathione delivery systems. J. Am. Coll. Nutr. 5:1986;137-151.
68. Anderson M.E., Meister A. Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate. FASEB J. 3:1989a;1632-1636.
69. Jain A., Madsen D.C., Auld P.A.M., Frayer W.W., Schwartz M.K., Meister A., Martensson J. L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid deficient diet. J. Nutr. 125:1995;851-856.
70. Breborowicz A., Witowski J., Martis L., Oreopoulos D.G. Enhancement of viability of human peritoneal mesothelial cells with glutathione precursor: L-2 oxothiazolidine-4-carboxylate. Adv. Peritoneal Dialysis. 9:1993;21-24.
71. Weitberg A.B. The effect of L-2-oxothiazolidine on glutathione levels in cultured mammalian cells. Mutat. Res. 191:1987;189-191.
72. Shug A.L., Madsen D.C. Protection of the ischemic rat heart by procysteine and amino acids. J. Nutr. Biochem. 5:1994;3356-3359.
73. D.M. Wilson, R.D. White, L.E. Webb, J.G. Bender, L.L. Pippin, D.L. Goldberg, Amelioration of AZT-induced bone marrow hypoplasia in mice cotreated with glutathione prodrug, Procysteine™ (abstract)., 9th Int. Conf. AIDS, June 7-11, 1993, Berlin.
74. S. Josephs, C. Asuncion, C. Sun, P. Jacobson, L. Webb, Procysteine (L-2 oxothiazolidine-4-carboxylic acid) reduces the toxicity of AZT (zidovudine) and enhances the antiviral activity of AZT in cultured peripheral blood mononuclear cells (PBMC), abstract 230. 10th Int. Conf. AIDS, June 6-11, 1993, Berlin.
75. Lederman M.M., Georger D., Dando S., Schmeizer R., Averill L., Goldberg D. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor α-chain. J. Acq. Immune Def. Syndr. 8:1995;107-115.
76. Porta P., Aebi S., Summer K., Lauterburg B.H. L-2-oxothiazolidine-4 carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J. Pharmacol. Exp. Ther. 257:1991;331-334.
77. Kalayjian R.C., Skowron G., Emgushov R.-T., Chance M., Spell S.A., Borum P.R., Webb L.S., Mayer K.H., Jackson J.B., Yen-Lieberman B., Story K.O., Rowe W.B., Thompson K., Goldberg D., Trimbo S., Lederman M.M. A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV infected subjects. J. Acq. Immune Def. Syndr. 7:1994;369-374.
78. Anderson M.E., Meister A. Transport and direct utilization of γ- glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 80:1983;707-711.
79. Pileblad E., Magusson T. Increase in rat brain glutathione following intracerebroventricular administration of γ-glutamylcysteine. Biochem. Pharmacol. 44:1992;895-903.
80. Puri R.N., Meister A. Transport of glutathione, as γ-glutamylcysteinylglycyl ester, into liver and kidney. Proc. Natl. Acad. Sci. U.S.A. 80:1983;5258-5260.
81. Anderson M.E., Powrie F., Puri R.N., Meister A. Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. 239:1985;538-548.
82. Anderson M.E., Underwood M., Bridges R.J., Meister A. Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 3:1989;2527-2531.
83. Martensson J., Steinherz R., Jain A., Meister A. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8727-8731.
84. Steinherz R., Martensson J., Wellner D., Meister A. Transport of into the brain of buthionine sulfoximine, an inhibitor of glutathione synthesis, is facilitated by esterification and administration of dimethylsulfoxide. Brain Res. 518:1990;115-119.
85. Anderson M.E., Levy E.J., Meister A. Preparation and use of glutathione monoesters. Methods Enzymol. 234:1994;492-499.
86. Levy E.J., Anderson M.E., Meister A. Preparation and properties of glutathione diethyl ester and related derivatives. Methods Enzymol. 234:1994;499-505.
87. Levy E.J., Anderson M.E., Meister A. Transport of glutathione diethyl ester into human cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9171-9175.
88. Minhas H., Thornalley P.J. Comparison of the delivery of reduced glutathione into P388D1 cells by reduced glutathione and its mono- and diethyl-ester derivatives. Biochem. Pharmacol. 49:1995;1475-1482.